# SigmaGraft Inc – FDA Inspection, Apr 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/sigmagraft-inc/703b6ad8-a7f3-4424-848f-9ea6b59b663a
Source feed: FDA_Inspections

> FDA inspection 1254544 of SigmaGraft Inc, April 25, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254544
- Company Name: SigmaGraft Inc
- Inspection Date: 2025-04-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1086611 - 2019-03-07
- [FDA Inspection 866325 - 2014-02-11](https://www.keypedia.com/records/fda_inspections/sigmagraft-inc/37b1df0a-aaa5-41bf-84ea-4e0ac5194433)
- FDA Inspection 722533 - 2011-05-02

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/melsomar-r-ramos/395e7ddc-ed98-455a-a143-0ee5f46804f4)

Company: https://www.keypedia.com/companies/sigmagraft-inc/4a1f2860-52f0-475a-ad24-b89f3b73a921

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b